Skip to main content
Figure 2 | PathoGenetics

Figure 2

From: Unraveling the disease pathogenesis behind lethal hydrolethalus syndrome revealed multiple changes in molecular and cellular level

Figure 2

Average percentage of bromodeoxyuridine-positive, proliferative control and hydrolethalus syndrome neuronal progenitor cells. The amount of the proliferation is 1.7% in control cells compared with 7.9% in hydrolethalus syndrome (HLS) cells. Results are represented as the mean from three independent experiments. The p-value between groups is p < 0.001.

Back to article page